An AI-Powered Blood Test to Detect Cancer Using NanoDSF - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2021

An AI-Powered Blood Test to Detect Cancer Using NanoDSF

(1) , (2) , (3, 4) , (5) , (1) , (3) , (6) , (7) , (8) , (8) , (8) , (1, 9) , (1, 9) , (1, 9) , (1)
1
2
3
4
5
6
7
8
9
Rémi Eyraud
  • Function : Author
  • PersonId : 1093518
Anton A Bougaev
  • Function : Author
Soazig Malesinski
François Devred

Abstract

Glioblastoma is the most frequent and aggressive primary brain tumor. Its diagnosis is based on resection or biopsy that could be especially difficult and dangerous in the case of deep location or patient comorbidities. Monitoring disease evolution and progression also requires repeated biopsies that are often not feasible. Therefore, there is an urgent need to develop biomarkers to diagnose and follow glioblastoma evolution in a minimally invasive way. In the present study, we described a novel cancer detection method based on plasma denaturation profiles obtained by a non-conventional use of differential scanning fluorimetry. Using blood samples from 84 glioma patients and 63 healthy controls, we showed that their denaturation profiles can be automatically distinguished with the help of machine learning algorithms with 92% accuracy. Proposed high throughput workflow can be applied to any type of cancer and could become a powerful pan-cancer diagnostic and monitoring tool requiring only a simple blood test.
Fichier principal
Vignette du fichier
cancers-13-01294.pdf (1.03 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03169412 , version 1 (15-03-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Philipp A Tsvetkov, Rémi Eyraud, Stéphane Ayache, Anton A Bougaev, Soazig Malesinski, et al.. An AI-Powered Blood Test to Detect Cancer Using NanoDSF. Cancers, 2021, 13 (6), pp.1294. ⟨10.3390/cancers13061294⟩. ⟨hal-03169412⟩
248 View
179 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More